Read More

Why Alzheimers-Drug Developer Cassava Sciences Stock Is Trending

The top-line results showed no decline in cognition scores in patients with mild Alzheimer's disease who received simufilam continuously for 24 months. "We're fighting Alzheimer's disease by testing simufilam, a new type of drug that has a completely different mechanism of action from monoclonal antibody drug treatments," said Remi Barbier, CEO of Cassava.

SAVA

Read More

Why Enphase Energy Stock Is Charging Today

Enphase shares are trading higher due in part to an upgrade from Oppenheimer analyst Colin Rusch who upgraded the stock from Perform to Outperform and announced a $133 price target on Wednesday. Additionally, BMO Capital analyst Ameet Thakkar maintained Enphase Energy with a Market Perform and raised the price target from $106 to $110 following the earnings report.

ENPH

Read More

E.l.f. Beauty Shares Climb After Q3 Earnings Beat, Raises 2024 Guidance Above Estimates

E.l.f. Beauty reported quarterly earnings of 74 cents per share, beating the analyst consensus estimate of 51 cents by 45.1% and representing a 54.17% increase over earnings of 48 cents per share from the same period last year. Quarterly sales clocked in at $270.94 million which beat the analyst consensus estimate of $231.13 million by 17.23%. This is a 84.9% increase over sales of $146.54 million year-over-year.

ELF

Read More

Cybersecurity Giant Fortinet Stocks Shoots Higher – Investors Cheer Q4 Performance, Outlook

Fortinet reported quarterly earnings of 51 cents per share which beat the analyst consensus estimate of 43 cents by 18.6%. The company reported quarterly sales of $1.42 billion, beating the analyst consensus estimate of $1.41 billion by 0.78% and representing a 10.68% increase over sales of $1.28 billion from the same period last year.

FTNT

Read More

Enphase Energy Q4 Performance: Revenue Shortfall, Subpar Outlook And More

Enphase Energy reported quarterly adjusted earnings of 54 cents per share which missed the analyst consensus estimate of 55 cents by 1.82% and is a 64.24% decrease over earnings of $1.51 per share from the same period last year. Quarterly sales clocked in at $302.57 million, missing the analyst consensus estimate of $328.25 million by 7.82% and representing a 58.25% decrease over sales of $724.65 million year-over-year.

ENPH

Read More

What’s Going On With Chinese EV-Maker XPeng Stock?

Shares of several Chinese companies, including XPeng, are climbing Tuesday as the Chinese government continues to plan initiatives to prop up the country's slumping economy. On Monday night, Bloomberg reported China President Xi Jinping will be briefed on the latest market conditions and policy initiatives by regulators including the China Securities Regulatory Commission as soon as Tuesday.

XPEV